The cost implication of primary prevention in the HOPE 3 trial.
暂无分享,去创建一个
S. Yusuf | J. Bosch | Hyejung Jung | E. Lonn | A. Gafni | A. Lamy | Balakumar Swaminathan | W. Tong
暂无分享,去创建一个
S. Yusuf | J. Bosch | Hyejung Jung | E. Lonn | A. Gafni | A. Lamy | Balakumar Swaminathan | W. Tong